Article
Human leukocyte antigen alleles associate with COVID-19 vaccine immunogenicity and risk of breakthrough infection.
Nature medicine - 1 Jan 2023
Mentzer Alexander J, O'Connor Daniel, Bibi Sagida, Chelysheva Irina, Clutterbuck Elizabeth A, Demissie Tesfaye, Dinesh Tanya, Edwards Nick J, Felle Sally, Feng Shuo, Flaxman Amy L, Karp-Tatham Eleanor, Li Grace, Liu Xinxue, Marchevsky Natalie, Godfrey Leila, Makinson Rebecca, Bull Maireid B, Fowler Jamie, Alamad Bana, Malinauskas Tomas, Chong Amanda Y, Sanders Katherine, Shaw Robert H, Voysey Merryn, Snape Matthew D, Pollard Andrew J, Lambe Teresa, Knight Julian C
Abstract excerpt
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine immunogenicity varies between individuals, and immune responses correlate with vaccine efficacy. Using data from 1,076 participants enrolled in ChAdOx1 nCov-19 vaccine efficacy trials in the United Kingdom, we found that inter-individual variation in normalized antibody responses against SARS-CoV-2 spike and its receptor-binding domain (RBD) at...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
